Cargando…
Hippocampal Injections of Oligomeric Amyloid β-peptide (1–42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway
Increasing evidence suggests that abnormal brain accumulation of soluble rather than aggregated amyloid-β(1–42) oligomers (Aβo((1–42))) plays a causal role in Alzheimer’s disease (AD). However, as yet, animal’s models of AD based on oligomeric amyloid-β(1–42) injections in the brain have not investi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707555/ https://www.ncbi.nlm.nih.gov/pubmed/26793098 http://dx.doi.org/10.3389/fnagi.2015.00245 |